1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α

International Immunopharmacology

Volumn 31, Issue , 2016, Pages 98-104

  Jakubowski, Andrzej ^a   Sternak, Magdalena ^b   Jablonski, Konrad ^a   Ciszek Lenda, Marta ^a   Marcinkiewicz, Janusz ^a   Chlopicki, Stefan ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

1 Methylnicotynamide; Concanavalin A; IL 4; Murine hepatic injury; Prostacyclin

Indexed keywords

1 METHYLNICOTINAMIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBACYCLIN; CONCANAVALIN A; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 4; PROSTACYCLIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; BENZOFURAN DERIVATIVE; NICOTINAMIDE; PROPIONIC ACID DERIVATIVE; PROSTACYCLIN RECEPTOR; RO3244794; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HISTOPATHOLOGY; KUPFFER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; SURVIVAL RATE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DRUG EFFECTS; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; BENZOFURANS; CELLS, CULTURED; CHEMICAL AND DRUG INDUCED LIVER INJURY; CONCANAVALIN A; DEXAMETHASONE; EPOPROSTENOL; INTERLEUKIN-4; LIVER; MICE; MICE, INBRED BALB C; NIACINAMIDE; PROPIONATES; RECEPTORS, EPOPROSTENOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84950269297     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.11.032     Document Type: Article

References (43)

1. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
2. H. Tilg, R. Jalan, A. Kaser, N.A. Davies, F.A. Offner, S.J. Hodges, and et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis J. Hepatol. 38 2015 419 425
3. G. Tiegs, J. Hentschel, and A. Wendel A T cell-dependent experimental liver injury in mice inducible by concanavalin A J. Clin. Invest. 90 1992 196 203
4. F. Gantner, M. Leist, A.W. Lohse, P.G. Germann, and G. Tiegs Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor Hepatology 21 1995 190 198
5. S. Kusters, F. Gantner, G. Kunstle, and G. Tiegs Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A Gastroenterology 111 1996 462 471
6. Y. Tagawa, S. Kakuta, and Y. Iwakura Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis Eur. J. Immunol. 28 1998 4105 4113
7. K. Seino, N. Kayagaki, K. Takeda, K. Fukao, K. Okumura, and H. Yagita Contribution of Fas ligand to T cell-mediated hepatic injury in mice Gastroenterology 113 1997 1315 1322
8. T. Kondo, T. Suda, H. Fukuyama, M. Adachi, and S. Nagata Essential roles of the Fas ligand in the development of hepatitis Nat. Med. 3 1997 409 413
9. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, and et al. Lethal effect of the anti-Fas antibody in mice Nature 364 1993 806 809
10. D. Rossi, and A. Zlotnik The biology of chemokines and their receptors Annu. Rev. Immunol. 18 2000 217 242
11. A. Zlotnik, and O. Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127
12. M. Tamaru, K. Nishioji, Y. Kobayashi, Y. Watanabe, Y. Itoh, T. Okanoue, and et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10 Cytokine 12 2000 299 308
13. S. Chlopicki, J. Swies, A. Mogielnicki, W. Buczko, M. Bartus, M. Lomnicka, and et al. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway Br. J. Pharmacol. 152 2007 230 239
14. K. Bryniarski, R. Biedron, A. Jakubowski, S. Chlopicki, and J. Marcinkiewicz Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin Eur. J. Pharmacol. 578 2008 332 338
15. A. Wozniacka, M. Wieczorkowska, J. Gebicki, and A. Sysa-Jedrzejowska Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study Clin. Exp. Dermatol. 30 2005 632 635
16. M. Sternak, A. Jakubowski, E. Czarnowska, E.M. Slominska, R.T. Smolenski, M. Szafarz, and et al. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis Int. Immunopharm. 28 2015 105 114
17. K. Przyborowski, M. Wojewoda, B. Sitek, A. Zakrzewska, A. Kij, K. Wandzel, and et al. Effects of 1-methylnicotinamide (MNA) on exercise capacity and endothelial response in diabetic mice PLoS One 10 2015 e0130908
18. M. Sternak, T.I. Khomich, A. Jakubowski, and et al. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse Pharmacol. Rep. 62 2010 483 493
19. M.H. Julius, E. Simpson, and L.A. Herzenberg A rapid method for the isolation of functional thymus-derived murine lymphocytes Eur. J. Immunol. 3 1973 645 649
20. S.K. Suvarna, C. Layton, and J.D. Bancroft Bancrotf's theory and practise of histological techniques seventh edition 2013 Churchill Livingstone Elsevier London
21. G.L. Lu Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology third edition 1968 McGraw-Hill New York
22. K.R. Bley, A. Bhattacharya, D.V. Daniels, J. Gever, A. Jahangir, C. O'Yang, and et al. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists Br. J. Pharmacol. 147 2006 335 345
23. S. Ohta, M. Nakamuta, M. Fukushima, M. Kohjima, K. Kotoh, M. Enjoji, and et al. Beraprost sodium, a prostacyclin (PGI2) analogue, ameliorates concanavalin A-induced liver injury in mice Liver Int. 25 2005 1061 1068
24. F. Guarner, N.K. Boughton-Smith, G.J. Blackwell, and S. Moncada Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse Hepatology 8 1988 248 253
25. E. Gedik, S. Girgin, B.D. Obay, H. Ozturk, H. Ozturk, and H. Buyukbayram Iloprost, a prostacyclin (PGI 2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats Acta Cir. Bras. 24 2009 226 232
26. C.-J. Chu, C.-C. Hsiao, T.-F. Wang, C.-Y. Chan, F.-Y. Lee, F.-Y. Chang, and et al. Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure World J. Gastroenterol. 11 2005 232 236
27. T.-T. Hong, J. Huang, T.D. Barrett, and B.R. Lucchesi Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis Am. J. Physiol. Heart Circ. Physiol. 294 2008 H145 H155
28. S.M. Wilson, N.A. Sheddan, R. Newton, and M.A. Giembycz Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release Mol. Pharmacol. 79 2011 586 595
29. S.M. Wilson, P. Shen, C.F. Rider, S.L. Traves, D. Proud, R. Newton, and et al. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells J. Immunol. 183 2009 6788 6799
30. H. Yin, L. Cheng, R. Langenbach, and C. Ju Prostaglandin I2 and E2 mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury Hepatology 45 2007 159 169
31. H. Mizuhara, M. Uno, N. Seki, M. Yamashita, M. Yamaoka, T. Ogawa, and et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis Hepatology 23 1996 1608 1615
32. B.H. Mizuhara, E.O. Neill, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, and et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 J. Exp. Med. 179 1994 1529 1537
33. S. Toyabe, S. Seki, T. Iiai, K. Takeda, K. Shirai, H. Watanabe, and et al. Requirement of IL-4 and liver NK1 + T cells for concanavalin A-induced hepatic injury in mice J. Immunol. 159 1997 1537 1542
34. J. Marcinkiewicz, and B.M. Chain Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP Cell. Immunol. 149 1993 303 314 (Internet)
35. J. Marcinkiewicz Regulation of cytokine production by eicosanoids and nitric oxide Arch. Immunol. Ther. Exp. 45 1997 163 167
36. A.N. Hata, and R.M. Breyer Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol. Ther. 103 2004 147 166
37. W. Zhou, T.S. Blackwell, K. Goleniewska, J.F. O'Neal, G.A. Fitzgerald, M. Lucitt, and et al. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells J. Leukoc. Biol. 81 2007 809 817
38. Y. Takahashi, S. Tokuoka, T. Masuda, Y. Hirano, M. Nagao, H. Tanaka, and et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice Br. J. Pharmacol. 137 2002 315 322
39. K. Nagao, H. Tanaka, M. Komai, T. Masuda, S. Narumiya, and H. Nagai Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice Am. J. Respir. Cell Mol. Biol. 29 2003 314 320
40. S.L. Dorris, and R.S. Pu Jr PGI 2 as a regulator of inflammatory diseases Mediat. Inflamm. 2012 2012 1 9
41. J. Marcinkiewicz Prostanoids and MPO Á halide system products as a link between innate and adapti v e immunity Immunol. Lett. 89 2003
42. M. Nakamura, M. Shibazaki, Y. Nitta, and Y. Endo Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: the role of Kupffer cells J. Hepatol. 28 1998 991 999
43. R. Biedroń, M. Ciszek, M. Tokarczyk, M. Bobek, M. Kurnyta, E.M. Słominska, and et al. 1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages Arch. Immunol. Ther. Exp. 56 2008 127 134